326 related articles for article (PubMed ID: 7533608)
21. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
[TBL] [Abstract][Full Text] [Related]
22. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy.
Hyde SC; Gill DR; Higgins CF; Trezise AE; MacVinish LJ; Cuthbert AW; Ratcliff R; Evans MJ; Colledge WH
Nature; 1993 Mar; 362(6417):250-5. PubMed ID: 7681548
[TBL] [Abstract][Full Text] [Related]
23. Human cystic fibrosis airway epithelia have reduced Cl- conductance but not increased Na+ conductance.
Itani OA; Chen JH; Karp PH; Ernst S; Keshavjee S; Parekh K; Klesney-Tait J; Zabner J; Welsh MJ
Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10260-5. PubMed ID: 21646513
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological approaches to correcting the ion transport defect in cystic fibrosis.
Roomans GM
Am J Respir Med; 2003; 2(5):413-31. PubMed ID: 14719993
[TBL] [Abstract][Full Text] [Related]
25. Role of K(V)LQT1 in cyclic adenosine monophosphate-mediated Cl(-) secretion in human airway epithelia.
Mall M; Wissner A; Schreiber R; Kuehr J; Seydewitz HH; Brandis M; Greger R; Kunzelmann K
Am J Respir Cell Mol Biol; 2000 Sep; 23(3):283-9. PubMed ID: 10970817
[TBL] [Abstract][Full Text] [Related]
26. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.
Mall M; Grubb BR; Harkema JR; O'Neal WK; Boucher RC
Nat Med; 2004 May; 10(5):487-93. PubMed ID: 15077107
[TBL] [Abstract][Full Text] [Related]
27. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
28. Gene therapy for the respiratory manifestations of cystic fibrosis.
Korst RJ; McElvaney NG; Chu CS; Rosenfeld MA; Mastrangeli A; Hay J; Brody SL; Eissa NT; Danel C; Jaffe HA
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S75-87. PubMed ID: 7533609
[TBL] [Abstract][Full Text] [Related]
29. Dysfunction of CFTR bearing the delta F508 mutation.
Welsh MJ; Denning GM; Ostedgaard LS; Anderson MP
J Cell Sci Suppl; 1993; 17():235-9. PubMed ID: 7511616
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological treatment of the ion transport defect in cystic fibrosis.
Roomans GM
Expert Opin Investig Drugs; 2001 Jan; 10(1):1-19. PubMed ID: 11116277
[TBL] [Abstract][Full Text] [Related]
31. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
Stanton BA
Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
[TBL] [Abstract][Full Text] [Related]
32. Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets.
Haq IJ; Gray MA; Garnett JP; Ward C; Brodlie M
Thorax; 2016 Mar; 71(3):284-7. PubMed ID: 26719229
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus-mediated generation of cAMP-stimulated Cl- transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method.
Zabner J; Wadsworth SC; Smith AE; Welsh MJ
Gene Ther; 1996 May; 3(5):458-65. PubMed ID: 9156806
[TBL] [Abstract][Full Text] [Related]
34. [Physiopathology of cystic fibrosis lung disease].
Chinet T
Rev Mal Respir; 1999 Jun; 16(3):339-45. PubMed ID: 10472642
[TBL] [Abstract][Full Text] [Related]
35. Fluid transport across cultures of human tracheal glands is altered in cystic fibrosis.
Jiang C; Finkbeiner WE; Widdicombe JH; Miller SS
J Physiol; 1997 Jun; 501 ( Pt 3)(Pt 3):637-47. PubMed ID: 9218222
[TBL] [Abstract][Full Text] [Related]
36. Cystic fibrosis: a disease of vulnerability to airway surface dehydration.
Boucher RC
Trends Mol Med; 2007 Jun; 13(6):231-40. PubMed ID: 17524805
[TBL] [Abstract][Full Text] [Related]
37. Parallel improvement of sodium and chloride transport defects by miglustat (n-butyldeoxynojyrimicin) in cystic fibrosis epithelial cells.
Noël S; Wilke M; Bot AG; De Jonge HR; Becq F
J Pharmacol Exp Ther; 2008 Jun; 325(3):1016-23. PubMed ID: 18309088
[TBL] [Abstract][Full Text] [Related]
38. Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer.
Olsen JC; Johnson LG; Stutts MJ; Sarkadi B; Yankaskas JR; Swanstrom R; Boucher RC
Hum Gene Ther; 1992 Jun; 3(3):253-66. PubMed ID: 1379473
[TBL] [Abstract][Full Text] [Related]
39. Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro.
Zabner J; Couture LA; Smith AE; Welsh MJ
Hum Gene Ther; 1994 May; 5(5):585-93. PubMed ID: 7519884
[TBL] [Abstract][Full Text] [Related]
40. Ability of adenovirus vectors containing different CFTR transcriptional cassettes to correct ion transport defects in CF cells.
Jiang C; O'Connor SP; Armentano D; Berthelette PB; Schiavi SC; Jefferson DM; Smith AE; Wadsworth SC; Cheng SH
Am J Physiol; 1996 Oct; 271(4 Pt 1):L527-37. PubMed ID: 8897899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
